Sorafenib

Nexavar

Kinase Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 18.8% PA Req: 99.4% 5 Manufacturers 5 ANDAs

Sorafenib targets specific kinase enzymes involved in cancer cell growth and proliferation.

Covered Lives

Generic Manufacturers

BAYER HEALTHCARE PHARMACEUTICALS INCDR REDDYS LABORATORIES LTDMYLAN PHARMACEUTICALS INCTEVA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTDYABAO PHARMACEUTICAL CO LTD BEIJING

Explore in the Ecosystem

rxsaver.aiCompare prices for Sorafenib drfinder.aiFind doctors who prescribe Sorafenib rxpbm.aiPBM spread analysis for Sorafenib clinicalrx.aiClinical profile: Sorafenib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.